Literature DB >> 25440441

[Results of a telemedicine program for primary care patients with type 2 diabetes].

Jesús López-Torres1, Joseba Rabanales2, Rafael Fernández3, Francisco J López4, Llanos Panadés5, Victoria Romero4.   

Abstract

OBJECTIVE: To evaluate the impact of a telemedicine program on self-perceived health in patients with type 2 diabetes in primary care, as well as patient acceptance of and satisfaction with this program.
METHOD: We conducted an 18-month follow-up through telemedicine in 52 diabetic patients. The study design was non-experimental (before and after). In addition to weekly electronic transmission of fasting glucose levels, we regularly provided advice to patients about healthy habits.
RESULTS: No statistically significant differences were observed when mean blood glucose values were compared during follow-up. However, at the end of participation, the mean score in self-perceived health was significantly higher than at the initial assessment (70.5±12.8 vs. 62.8±15.0, p=0.02). After 18 months of participation in the telemedicine program, 57.7% of patients were satisfied and 38.5% were very satisfied.
CONCLUSIONS: Although glycemic control did not improve during the follow-up, electronic transmission of information was found to be feasible and satisfactory for patients. The patients reported a higher level of self-perceived health.
Copyright © 2014 SESPAS. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Atención primaria de salud; Diabetes mellitus tipo 2; Diabetes mellitus type 2; Primary health care; Telemedicina; Telemedicine

Mesh:

Substances:

Year:  2014        PMID: 25440441     DOI: 10.1016/j.gaceta.2014.08.003

Source DB:  PubMed          Journal:  Gac Sanit        ISSN: 0213-9111            Impact factor:   2.139


  3 in total

1.  Type 2 Diabetes Patients Benefit from the COMODITY12 mHealth System: Results of a Randomised Trial.

Authors:  Przemysław Kardas; Krzysztof Lewandowski; Stefano Bromuri
Journal:  J Med Syst       Date:  2016-10-08       Impact factor: 4.460

2.  Cross-sectional study about the use of telemedicine for type 2 diabetes mellitus management in Spain: patient's perspective. The EnREDa2 Study.

Authors:  Patricia Rodríguez-Fortúnez; Josep Franch-Nadal; José A Fornos-Pérez; Fernando Martínez-Martínez; Hector David de Paz; María Luisa Orera-Peña
Journal:  BMJ Open       Date:  2019-06-22       Impact factor: 2.692

3.  [Effectiveness and economic impact of a program of integrated care with telemedicine support on insulin-treated type 2 diabetic patients (Study GITDIABE)].

Authors:  Jose M Inoriza; Annabel Ibañez; Xavier Pérez-Berruezo; Cristina Inoriza-Nadal; Jordi Coderch
Journal:  Aten Primaria       Date:  2016-08-08       Impact factor: 1.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.